Case Report of Fibrocartilaginous Embolic Myelopathy of the Spinal Cord in a Female Dog
Small Animal Advances · 2022
DOI: 10.58803/saa.v1i1.1 ↗Kurz gefasst
Fallbericht in der Zeitschrift Small Animal Advances, 2022. Verfasst von Sina Salavati und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Fibrocartilaginous embolic myelopathy is a non-progressive injury in the spinal cord that can cause infarction in veins of spinal parenchyma which leads to ischemia and necrosis. Case report: Fibrocartilaginous embolic myelopathy was diagnosed in a 4-year-old, female, Spitz dog using the clinical neurological examination. The dog was hospitalized, and the treatment including supportive treatment and Cortone was set up for three weeks. Then Diazepam and Methocarbamol were added to the prescription and treatment continued for two weeks. A general improvement was noted after three weeks, and the dog could stand perfectly after 5 weeks.
Conclusion
Three weeks of supportive treatment, Cortone therapy as well as the addition of Diazepam and Methocarbamol to the treatment could help the dog to stand on its feet. However, cannot be ignored that knowing about the history of the dog played an important role in its treatment procedure.
Zitieren
APA
Salavati, S., Kafrashi, M. H., Babazadeh, D., & Raznahan, M. (2022). Case Report of Fibrocartilaginous Embolic Myelopathy of the Spinal Cord in a Female Dog. Small Animal Advances. https://doi.org/10.58803/saa.v1i1.1
Vancouver
Salavati S, Kafrashi MH, Babazadeh D, Raznahan M. Case Report of Fibrocartilaginous Embolic Myelopathy of the Spinal Cord in a Female Dog. Small Animal Advances. 2022. doi:10.58803/saa.v1i1.1
BibTeX
@article{Salavati2022,
author = {Salavati, Sina and Kafrashi, Muhammad H and Babazadeh, Daryoush and Raznahan, Mohammadreza},
title = {Case Report of Fibrocartilaginous Embolic Myelopathy of the Spinal Cord in a Female Dog},
journal = {Small Animal Advances},
year = {2022},
doi = {10.58803/saa.v1i1.1}
}
EUVIMED